Gessica Contesotto
Centre Hospitalier de Luxembourg(LU)University of Luxembourg(LU)Luxembourg Institute of Health(LU)
Publications by Year
Research Areas
Parkinson's Disease Mechanisms and Treatments, RNA regulation and disease, Dementia and Cognitive Impairment Research, MicroRNA in disease regulation, Gut microbiota and health
Most-Cited Works
- → Comprehensive blood metabolomics profiling of Parkinson’s disease reveals coordinated alterations in xanthine metabolism(2024)25 cited
- → Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes(2022)25 cited
- → Accurate long-read sequencing identified GBA1 as major risk factor in the Luxembourgish Parkinson’s study(2023)24 cited
- → Converging peripheral blood microRNA profiles in Parkinson's disease and progressive supranuclear palsy(2024)13 cited
- → Multi-cohort machine learning identifies predictors of cognitive impairment in Parkinson’s disease(2025)4 cited
- → Mixed effects models but not t-tests or linear regression detect progression of apathy in Parkinson’s disease over seven years in a cohort: a comparative analysis(2024)4 cited
- → Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease(2024)4 cited
- → Cardiovascular history and risk of idiopathic Parkinson’s disease: a cross-sectional observational study(2024)3 cited
- → Publisher Correction: Age at onset as stratifier in idiopathic Parkinson’s disease – effect of ageing and polygenic risk score on clinical phenotypes(2022)1 cited
- → Author Correction: Integrating digital gait data with metabolomics and clinical data to predict outcomes in Parkinson’s disease(2025)